The National Academies of Sciences, Engineering, and Medicine today issued a report recommending actions to contain and reverse the harmful societal effects of the prescription and illicit opioid epidemics. According to the report, requested by the Food and Drug Administration, it is possible to stem the escalating prevalence of opioid use disorder and other opioid-related harms without foreclosing access to opioids for patients suffering from pain, but that years of sustained and coordinated efforts will be required. Among other actions, the report recommends promoting more judicious prescribing of opioids, expanding access to treatment for opioid use disorder, preventing more overdose deaths, weighing societal impacts in opioid-related regulatory decisions, and investing in research to better understand the nature of pain and develop non-addictive alternatives.

Related News Articles

Headline
The National Institutes of Health today selected several universities to partner with communities in Kentucky, Massachusetts, New York and Ohio to study the…
Headline
The Food and Drug Administration yesterday announced changes to the prescribing information included in outpatient opioid pain medication labels.
Headline
The Agency for Healthcare Research and Quality is accepting comments through April 25 on a draft report on treatment for acute pain.
Headline
The AHA and the National Quality Forum today released a guide to help hospitals and health systems working to deliver innovative, high-quality telebehavioral…
Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…